Structure |
Chemical Name |
CAS |
MF |
|
methyl 6-chloro-3-nitropyrazine-2-carboxylate |
89690-75-5 |
C6H4ClN3O4 |
|
1-Bromodibenzothiophene |
65642-94-6 |
C12H7BrS |
|
Posaconazole Impurity 16 |
213381-02-3 |
C37H42F2N8O4 |
|
Ethyl 7-(Allyl(Methyl)Amino)-2-Amino-5-Fluoro-1H-Indole-3-Carboxylate |
|
C15H18FN3O2 |
|
FMOC-21-AMINO-4,7,10,13,16,19-HEXAOXAHENEICOSANOIC ACID |
882847-34-9 |
C30H41NO10 |
|
2-AMINO-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE |
4815-28-5 |
C9H12N2OS |
|
2-Iododibenzothiophene |
177586-41-3 |
C12H7IS |
|
PROSTAGLANDIN H2 |
42935-17-1 |
C20H32O5 |
|
Indole-3-carbinol |
700-06-1 |
C9H9NO |
|
Cabazitaxel N-3 |
859498-31-0 |
C57H61Cl6NO19 |
|
2‐ethylhexyl 4,6‐
dibroMothieno[3,4‐
b]thiophene‐2‐
carboxylate |
1160823-81-3 |
C15H18Br2O2S2 |
|
1-(1-Benzothiophen-4-yl)piperazine hydrochloride |
913614-18-3 |
C12H15ClN2S |
|
N-[4-[2-(2-AMino-4,5,6,7-tetrahydro-4,6-dioxo-1H-pyrrolo[2,3-d]pyriMidin-5-yl)ethyl]benzoyl]-L-glutaMic Acid |
193281-00-4 |
C20H21N5O7 |
|
RTI 4229-111 |
150653-91-1 |
C16H20Cl3NO2 |
|
4-[[6-[(1-Oxo-2-propen-1-yl)oxy]hexyl]oxy]benzoic acid 1,1'-(1,4-phenylene) ester |
123864-17-5 |
C38H42O10 |
|
(alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide |
521284-19-5 |
C16H16N2O4 |
|
(S)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diaMine |
314771-76-1 |
C18H16ClFN4O2 |
|
Bis(4-isopropylphenyl)iodonium chloride |
97671-66-4 |
C18H22ClI |
|
2-(PIPERAZIN-1-YL)-ACETIC ACID H2O |
37478-58-3 |
C6H12N2O2 |
|
9,9-BIS(METHOXYMETHYL)FLUORENE |
182121-12-6 |
C17H18O2 |
|
7-AMINO-3-(2-FUROYLTHIOMETHYL)-3-CEPHEM-4-CARBOXYLIC ACID |
80370-59-8 |
C13H12N2O5S2 |
|
7-CHLORO-BENZO[B]THIOPHENE-2-CARBOXYLIC ACID |
90407-15-1 |
C11H9ClO2S |
|
1-(5-Bromo-3-pyridyl)piperazine |
412347-30-9 |
C9H12BrN3 |
|
2-Oxazolidinone,3-[(5S)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-(phenylmethyl)-,(4S)- |
852148-49-3 |
C21H22FNO4 |
|
2-mercapto-3,5-dimethylthieno[2,3-d]pyrimidin-4(3H)-one |
51486-14-7 |
C8H8N2OS2 |
|
ethyl 4-formyl-1H-pyrrole-2-carboxylate |
7126-57-0 |
C8H9NO3 |
|
2,7-DIAZA-SPIRO[4.4]NONANE-2-CARBOXYLIC ACID TERT-BUTYL ESTER |
236406-49-8 |
C12H22N2O2 |
|
QUINUCLIDINE |
100-76-5 |
C7H13N |
|
6-nitrocoumarin |
2725-81-7 |
C9H5NO4 |
|
1-Boc-4-bromopyrazole |
1150271-23-0 |
C8H11BrN2O2 |
|
(S)-1-Amino-3-chloro-2-propanol hydrochloride |
34839-13-9 |
C3H9Cl2NO |
|
2,2'-BIPYRIMIDINE |
34671-83-5 |
C8H6N4 |
|
3,4-Dichloro-6-(trifluoromethyl)toluene |
74483-51-5 |
C8H5Cl2F3 |
|
BENZYL [2-AMINO-2-(HYDROXYIMINO)-1,1-DIMETHYLETHYL]CARBAMATE |
518047-98-8 |
C12H17N3O3 |
|
4,6-DICHLORO-2-(4-FLUOROPHENYL)PYRIMIDINE |
83217-30-5 |
C10H5Cl2FN2 |
|
4,7-Bis(2-bromo-5-thienyl)-2,1,3-benzothiadiazole |
288071-87-4 |
C14H6Br2N2S3 |
|
(1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone |
895152-66-6 |
C16H19NO |
|
Platinum, dichloro(1,2-cyclohexanediamine-N,N')-, [sp-4-2-(1R-trans)]- |
61848-66-6 |
C6H12Cl2N2Pt |
|
20-HYDROXY PROSTAGLANDIN E2 |
57930-95-7 |
C20H32O6 |
|
2,3,4,5-Tetrahydro-N,N-dimethyl-1-[(4-methylphenyl)sulfonyl]-1H-1-benzazepin-5-amine |
181210-18-4 |
C19H24N2O2S |
|
6-(Phthalimidomethyl)morphanthridine |
74860-00-7 |
C23H16N2O2 |
|
3-Amino-5-bromo-thiophene-2-carboxylic acid methyl ester |
107818-55-3 |
C6H6BrNO2S |
|
(3R,3αS,6αR)-Hydroxyhexa-hydrofuro[2,3-β]furan-3-yl acetate |
186488-43-7 |
C8H12O4 |
|
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione |
853029-57-9 |
C20H17BrN6O2 |
|
Methyl 5-chlorothiazole-2-carboxylate |
98136-57-3 |
C5H4ClNO2S |
|
4H-Pyrido[1,2-a]pyriMidin-4-one,2-hydroxy-9-Methyl- |
17326-09-9 |
C9H8N2O2 |
|
Dicyclohexyl-3,4,3',4'-tetracarboxylic dianhydride |
122640-83-9 |
C16H18O6 |
|
2-BroMo-5,7-dihydro-7,7-diMethyl-5-phenyl-indeno[2,1-b]carbazole |
1257220-44-2 |
C27H20BrN |
|
3-Bromo-1-tert-butyl-1H-pyrazolo-[3,4-d]pyrimidin-4-amine |
862728-61-8 |
C9H12BrN5 |
|
2-chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyriMidine-6-carboxylic acid |
1211443-58-1 |
C12H12ClN3O2 |
|
4-chloro- Benzo[b]thiophene |
66490-33-3 |
C8H5ClS |
|
Ethyl 3-broMopyrazolo[1,5-a]pyriMidine-2-carboxylate |
1394004-05-7 |
C9H8BrN3O2 |
|
(2E)-(R)-5-(diphenylamino)-5-oxopent-3-en-2-y13-(5-nitrocyclohex-1-en-1-y1)acylate |
900186-73-4 |
C26H26N2O5 |
|
Coumarin |
10172-75-5 |
C26H18O7 |
|
Danshen injection intermediate |
|
|
|
ethyl 4'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3,4,5-tetrahydro-[1,1'-biphenyl]-4-carboxylate |
1418754-60-5 |
C21H29BO4 |
|
sodium,2-methyl-3-phenyloxirane-2-carboxylic acid |
5449-12-7 |
C10H11NaO3 |
|
4,6-dichloro-2-cyclobutylpyrimidine |
1353856-95-7 |
C8H8Cl2N2 |
|
Azacitidine Isomer |
|
|
|
5-AMINO-2'-DEOXYURIDINE FREE BASE |
5536-30-1 |
C9H13N3O5 |
|
(1R-cis)-3-(phenylmethyl)-4-Thia-2,6-diazabicyclo[3.2.0]hept-2-en-7-one |
34103-69-0 |
C11H10N2OS |
|
(9H-fluoren-9-yl)methyl N-(carbamoylmethyl)carbamate |
115057-37-9 |
C17H16N2O3 |
|
Roxadustat Impurity |
1959587-35-9 |
C20H17NO6 |
|
Benzonitrile, 3-(2-amino-6-chloro-4-pyrimidinyl)-2-methyl- |
2239278-05-6 |
C12H9ClN4 |
|
Inosine API manufacturers |
|
|
|
3’-deoxyinosine |
|
|
|
(S)-2-(2,2,2-trifluoroethyl)piperazine dihydrochloride |
|
|
|
Acetoxy Ceftazidime Intermediate |
|
|
|
Flomoxef Intermediate FXMT |
|
|
|
2-Morpholino-6-oxo-1,6-dihydropyrimidine-4-carboxylic acid |
933686-76-1 |
C9H11N3O4 |
|
4-METHYL 6-HYDROXY 7-ACETOXY COUMARIN |
46895-13-0 |
C12H10O6 |
|
Pyrazole |
288-13-1 |
C3H4N2 |
|
9-OXO-11ALPHA,15S-DIHYDROXY-PROST-13E-EN-1-OIC-3,3,4,4-D4 ACID |
211105-33-8 |
C20H30D4O5 |
|
2,3,5,6-1H,4H-TETRAHYDROQUINOLIZINO[9,9A,1-GH]COUMARIN |
58336-35-9 |
C15H15NO2 |
|
3-Fluorobenzylamine |
100-82-3 |
C7H8FN |
|
DIMETHYL PYRAZINE-2,5-DICARBOXYLATE |
13051-89-3 |
C8H8N2O4 |
|
4-Pyrimidinecarboxylic acid |
31462-59-6 |
C5H4N2O2 |
|
(3R,4R,5R)-Oseltamivir |
|
|
|
4-Piperidinecarboxylic acid, 3-methyl-4-phenyl-, phenylmethyl ester, (3S,4R)- |
2357209-42-6 |
C20H23NO2 |
|
(9H-fluoren-9-yl)methyl (R)-(3-(2-bromophenyl)-1-(methylamino)-1-oxopropan-2-yl)carbamate |
|
|
|
Pyrimidine, 2-chloro-4-(4-chlorophenoxy)-5-fluoro- |
1503263-51-1 |
C10H5Cl2FN2O |
|
2',3'-Didehydro-2',3'-dideoxy-5'-acetate inosine |
130676-57-2 |
C12H12N4O4 |
|
(R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone |
101328-85-2 |
C11H13N3O |
|
(S)-2-Phenylpyrrolidine |
59347-91-0 |
C10H13N |
|
2-(2-pyridyl)isothiourea N-oxide hydrochloride |
2770-93-6 |
C6H8ClN3OS |
|
disodium tetrabromophthalate |
25357-79-3 |
C8Br4Na2O4 |
|
cytidylyl(5'->3')adenosine |
4833-63-0 |
C19H25N8O11P |
|
(S)-2-Amino-5-methoxytetralin Hydrochloride |
58349-17-0 |
C11H15NO.HCl |
|
1-(benzo[d][1,3]dioxol-5-yl)-2-bromopropan-1-one |
52190-28-0 |
C10H9BrO3 |
|
Ceftazidime Mother Nucleus Double-Bond Shift |
|
|
|
1,4-Diazepan-5-one hydrochloride |
208245-76-5 |
C5H11ClN2O |
|
1,5-Pentanediaminium, N1,N1,N1,N5,N5,N5-hexaethyl-, hydroxide (1:2) |
109591-12-0 |
C17H41N2O+ |
|
11-Prostaglandin F2a |
|
|
|
Piperazine, 1-(cyclobutylmethyl)- (9CI) |
82534-54-1 |
C9H18N2 |
|
N-desethyl Etonitazene |
2732926-26-8 |
C20H24N4O3 |
|
L-Cephalexin |
34632-04-7 |
C16H17N3O4S |
|
Rimonabant hydrochloride |
158681-13-1 |
C22H21Cl3N4O.ClH |
|
NA |
|
|
|
5-bromo-2-chloro-4’-ethoxydiphenylmethane |
461432-23-5 |
C15H14BrClO |
|
3-isobutylglutaric anhydride |
185815-59-2 |
C9H14O3 |